ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for tools Level up your trading with our powerful tools and real-time insights all in one place.

INZY Inozyme Pharma Inc

4.60
0.00 (0.00%)
20 May 2024 - Closed
Delayed by 15 minutes

Income Statement

Balance Sheet

Cash Flow

Quarter End Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 00000000
Operating Income -16.84M-15.39M-16.91M-19.53M-18.37M-16.39M-18.07M-22.81M
Pre Tax Income -16.88M-15.26M-16.37M-18.54M-17.4M-15.58M-16.64M-21.54M
Net Income -16.88M-15.26M-16.37M-18.54M-17.4M-15.58M-16.64M-21.54M
Preferred Dividends 00000000
Basic Earnings Per Share (EPS) 00000000
EBIT -16.94M-15.58M-17.11M-19.36M-18.4M-16.42M-18.05M-22.79M
EBITDA -16.66M-15.21M-16.72M-19.34M-18.16M-16.19M-17.87M-22.6M
Year End 31 December 2023 201820192020202120222023
USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)USD (US$)
Total Revenue 000000
Operating Income -11.59M-20.81M-57.04M-56.65M-68.68M-75.65M
Pre Tax Income -6.96M-19.72M-56.42M-56.62M-67.06M-71.17M
Net Income -6.96M-19.72M-56.42M-56.62M-67.06M-71.17M
Preferred Dividends 000000
Basic Earnings Per Share (EPS) -0.821-2.191-2.413-2.392-1.66-1.152
EBIT -7.25M-20.83M-57.04M-56.84M-68.99M-75.67M
EBITDA -11.57M-20.72M-56.82M-55.97M-67.93M-74.81M